Swamy K H, Joshi A, Rao G R
Antimicrob Agents Chemother. 1976 Jun;9(6):903-7. doi: 10.1128/AAC.9.6.903.
Miconazole, a potent antifungal agent, labilizes rat liver lysosomes. Its labilizing effect is followed by measuring the release of lysosomal hydrolases, namely, acid phosphatase, beta-glucuronidase, and arylsulfatase A. The effect of miconazole is concentration dependent in the range of 10(-5) to 1.2 x 10(-4) M. However, at higher concentrations, miconazole inhibits enzyme release but does not inhibit enzyme activities per se. The effect of miconazole depends on the drug/lysosome ratio and is influenced by the pH of the incubation media, being minimal at alkaline pH. Membrane-active drugs such as nystatin, 2-phenethyl-alcohol, hexachlorophene, and digitonin have been compared with miconazole for their lysosome-labilizing action. The effect of miconazole on the lysosomal membrane is confirmed by a decrease in turbidity of the lysosomal suspension.
咪康唑是一种强效抗真菌剂,它能使大鼠肝脏溶酶体不稳定。通过测量溶酶体水解酶(即酸性磷酸酶、β-葡萄糖醛酸酶和芳基硫酸酯酶A)的释放来跟踪其不稳定作用。咪康唑在10(-5)至1.2×10(-4) M范围内的作用呈浓度依赖性。然而,在较高浓度下,咪康唑会抑制酶的释放,但本身并不抑制酶的活性。咪康唑的作用取决于药物/溶酶体的比例,并受孵育介质pH值的影响,在碱性pH值下作用最小。已将制霉菌素、2-苯乙醇、六氯酚和洋地黄皂苷等膜活性药物与咪康唑的溶酶体不稳定作用进行了比较。溶酶体悬浮液浊度的降低证实了咪康唑对溶酶体膜的作用。